Multiple molecular pathways are activated by pro-inflammatory/pro-fibrotic cytokines (e.g., IL-6, IL-17, and TNF-α) and growth factors (e.g., TGF-β), which are increased in different ILD. Here, IL6 is linked to interstitial lung disease.